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Objective. To evaluate the association between provider characteristics and treatment
location and racial/ethnic minority patients’ knowledge of breast cancer treatment risks
and benefits.
Data Sources/Data Collection. Survey responses and clinical data from breast can-
cer patients of Detroit and Los Angeles SEER registries were merged with surgeon
survey responses (N 5 1,132 patients, 277 surgeons).
Study Design. Cross-sectional survey. Multivariable regression was used to identify
associations between patient, surgeon, and treatment setting factors and accurate
knowledge of the survival benefit and recurrence risk related to mastectomy and breast
conserving surgery with radiation.
Principal Findings. Half (51 percent) of respondents had survival knowledge, while
close to half (47.6 percent) were uncertain regarding recurrence knowledge. Minority
patients and those with lower education were less likely to have adequate survival
knowledge and more likely to be uncertain regarding recurrence risk than their coun-
terparts (po.001). Neither surgeon characteristics nor treatment location attenuated
racial/ethnic knowledge disparities. Patient–physician communication was significantly
(po.001) associated with both types of knowledge, but did not influence racial/ethnic
differences in knowledge.
Conclusions. Interventions to improve patient understanding of the benefits and risks
of breast cancer treatments are needed across surgeons and treatment setting, partic-
ularly for racial/ethnic minority women with breast cancer.
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Persistently high rates of mastectomy and wide geographic variation in
surgical treatments for early stage breast cancer (National Institutes of Health
1990; Nattinger et al. 2000; Morrow et al. 2001; Wennberg 2002; Baxter et al.
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2004) have raised concerns that many women may not be fully informed
about surgical treatment options (Katz and Hawley 2007). These concerns
have motivated laws in 20 states mandating that surgeons discuss both breast
conserving surgery (BCS) with radiation and mastectomy with all eligible
patients to ensure treatment decisions are informed (Nayfield et al. 1994;
Montini 1997). As well, having accurate knowledge of the risks and benefits
associated with treatment options has been identified as a key element of an
informed and a high quality medical decision (Rimer et al. 2004; Sepucha et al.
2007). Yet, studies have found low knowledge about the risks and benefits
associated with mastectomy and BCS with radiation even among women who
have been through treatment (Bluman et al. 2001; Fagerlin et al. 2006).
Moreover, racial/ethnic difference differences in breast cancer treatment
knowledge suggest that more vulnerable populations may be at a particular
disadvantage when it comes to making an informed treatment decision (Maly,
Leake, and Silliman 2003; Siminoff, Graham, and Gordon 2006; Polacek,
Ramos, and Ferrer 2007).
However, few studies have evaluated whether racial/ethnic differences
in breast cancer treatment knowledge are associated with other factors, such as
the type of provider and/or treatment setting. Although there is considerable
research showing that certain provider characteristics (e.g., procedure vol-
ume) and treatment setting factors (e.g., access to multidisciplinary care) have
positive impacts on quality of care (Gabel, Hilton, and Nathanson 1997;
Chang et al. 2001; McKee et al. 2002; Hu et al. 2003; Birkmeyer et al. 2005;
Hiotis et al. 2005; Hawley et al. 2006; Newman et al. 2006; Gilligan et al.
2007), it is not clear whether these factors influence informed decision making.
As well, while there is research documenting the importance of physician–
patient communication to patient satisfaction with the breast cancer treatment
decision making process (Bruera et al. 2002; Liang et al. 2002; Janz et al. 2004;
Maly, Leake, and Silliman 2004; Lantz et al. 2005; Thind and Maly 2006), less
is known about whether this interaction influences treatment knowledge.
Furthermore, there is virtually no research evaluating whether racial/ethnic
Address correspondence to Sarah T. Hawley, Ph.D., M.P.H., Division of General Medicine,
University of Michigan Health System and Ann Arbor VA Medical Center, 300 N. Ingalls Room
7C27, Ann Arbor, MI; e-mail: sarahawl@umich.edu. Angela Fagerlin, Ph.D., and Steven J. Katz,
M.D., M.P.H., are with the Division of General Medicine, University of Michigan Health System
and Ann Arbor VA Medical Center, Ann Arbor, MI. Dr. Fagerlin is also with the Center for
Behavioral and Decision Sciences in Medicine. Nancy K. Janz, Ph.D., is with the Department of
Health Behavior and Health Education, School of Public Health, University of Michigan, Ann
Arbor, MI.
Disparities in Breast Cancer Treatment Knowledge 1367
disparities in informed treatment decision making are associated with
provider characteristics or with where patients receive their treatment. The
purpose of this analysis was to evaluate the association between surgeon
characteristics, treatment setting, and knowledge about the risks and benefits




The patient and surgeon samples used in this study have been described
elsewhere (Katz et al. 2005a, b, 2007; Lantz et al. 2005; Fagerlin et al. 2006;
Hawley et al. 2006). Briefly, we performed a survey of a population-based
sample of 2,645 women with breast cancer diagnosed in Detroit and Los
Angeles (LA) metropolitan areas (12/2001–1/2003) and reported to the Sur-
veillance, Epidemiology and End Results (SEER) registry, of whom 2,382
were eligible. Inclusion criteria were (1) primary diagnosis of ductal carcinoma
in situ (DCIS) or invasive but not metastatic breast cancer, (2) no prior breast
cancer diagnosis, (3) age 79 years or younger, (4) receipt of a definitive surgical
procedure, and (5) ability to complete a self-administered questionnaire in
English or Spanish. Women with lobular carcinoma in situ were excluded
because of different treatment recommendations for this type of cancer. Asian
women in Los Angeles were also excluded because they were enrolled in
other SEER studies. All cases of DCIS and an approximate 20 percent random
sample of invasive breast cancer cases were accrued into the study from
December 2001–January 2003. African American women were also over-
sampled to increase their representation in the dataset. The response rate was
77.4 percent (N 5 1,844). Nonrespondents to the survey were more likely to be
older, nonwhite, and have advanced disease based on SEER data. The median
time between diagnosis and survey response was approximately 7 months.
Pathology reports were used to identify surgeons in the Detroit and LA areas
(N 5 456) for 98.5 percent of the patient sample. Surgeons were contacted by
mail and asked to participate in a brief, self-administered survey to evaluate
their perspectives about surgical treatment for breast cancer. The surgeon
response rate was 80.0 percent (N 5 365). Surgeons who did not complete the
survey did not differ significantly from included surgeons on gender or years
in practice.
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Data Collection and Management
The data collection and management procedures for the patient and surgeon
surveys have been described in detail elsewhere (Katz et al. 2005a, b; Lantz
et al. 2005; Fagerlin et al. 2006; Hawley et al. 2006). The patient survey
protocol involved alerting physicians listed on the SEER record of the inten-
tion to survey their patients (o1 percent of potential respondents were ex-
cluded because of physician concerns). Potential participants were mailed an
introductory letter, followed by a telephone call to ascertain eligibility. Eligible
subjects were mailed the questionnaire in English or Spanish and a small
incentive ($10 grocery store coupon). We followed the Dillman method for
both patient and surgeon surveys——which involved a postcard reminder and
subsequent mailings to nonresponders——to maximize response rates (Dillman
1978). SEER clinical data were gathered from medical records and merged
with patient survey data by SEER staff using patient identification numbers.
This research followed established protocols of the SEER registries in both
Detroit and LA for population-based research. All protocols were reviewed
and approved by Institutional Review Boards of the University of Michigan,
Wayne State University, and The University of Southern California.
Merged Dataset and Analytic Sample
Surgeon respondents were linked to patient respondents using unique iden-
tifiers derived from the pathology reports (94.6 percent). The final merged
dataset contained complete patient–surgeon dyad information for 65.0 per-
cent of accrued and eligible patients (N 5 1,547) and 69.7 percent of accrued
surgeons (N 5 318). Patients who were excluded from the merged dataset
because of lack of a surgeon match did not differ from included patients on age
at diagnosis, race/ethnicity, educational attainment, or disease behavior. We
restricted this analysis to women whose documented summary stage in SEER
was ductal carcinoma in situ (DCIS) I or II, and tumors of o5 cm based on
treatment guidelines of both the National Cancer Institute Physician Data
Query (NCI-PDQ) database and the National Comprehensive Cancer Net-
work (NCCN) that describe both mastectomy and BCS with radiation as
viable options for these types of cancer (National Cancer Institute 2007;
NCCN 2007). We excluded approximately 10 percent of the patient sample
who potentially had a clinical contraindication to BCS or mastectomy, based
on SEER information. These exclusions were predominantly because of a
contraindication to BCS, with the primary reason being a large tumor size
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relative to small breast size. With these exclusions, our final analytic sample
was 1,132 patients of 277 surgeons.
Measures
Dependent Variables. We evaluated two dependent variables, each reflecting
patient knowledge about the benefits and risks associated with mastectomy
and BCS with radiation (Fagerlin et al. 2006). The first dependent variable
was survival knowledge, measured with the question, ‘‘the chances of being
alive 5 years after surgery is the same for mastectomy as it is for lumpectomy
with radiation,’’ with response options ‘‘true,’’ ‘‘false,’’ or ‘‘don’t know.’’
Because there is clinical consensus that the two surgical options afford
equivalent 5-year survival (EBCTCG 2005), this measure was re-coded into
two categories; the proportion responding ‘‘true’’ (correct answer) versus
those responding ‘‘false’’ or ‘‘don’t know’’ (incorrect answer). The second
dependent variable was recurrence knowledge, measured with the question,
‘‘the chance that my breast disease will come back after treatment is the same
for mastectomy as for lumpectomy with radiation,’’ with the same response
options (true, false, don’t know). To account for the fact that recent data
suggest greater equivalence in local recurrence risk between mastectomy and
BCS with radiation than was generally believed in 2002 when this study was
implemented (EBCTGC 2005), the three response options were retained in
analysis of recurrence knowledge.
Independent Variables. Patient demographics included age at diagnosis, race/
ethnicity (white, African American, Latina/other), education (high school
graduate or less versus some college or more), and marital status (married or
partnered versus not married). We also evaluated annual family income,
including a missing category to account for the high proportion of respondents
who did not answer this question ( $50,000 per year,o$50,000 per year,
missing). These variables were taken from the patient survey, and age at
diagnosis and race/ethnicity were updated from the SEER record if missing
on the survey. Race/ethnicity was assessed using the National Health
Interview Survey format with race and ethnicity as separate questions.
Respondents of mixed race/ethnicity were allowed to choose ‘‘other’’ for
race, ethnicity, or both questions. The final categories used for these analyses
were: non-Hispanic white (white), non-Hispanic African American (AA), or
Latina/other.
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The clinical variables used in the analysis taken from the SEER record
were the tumor size in centimeters and tumor behavior (DCIS or invasive).
We chose these variables because this information is generally available at
the time of surgery consultation, while tumor pathologic stage is not available
until after the biopsy. We also evaluated respondents’ self-reported family
history of breast cancer (first-degree relative, other relative, none).
We included a measure of the treatment setting where the patient
was treated based on prior work showing an association between a
multidisciplinary setting and higher quality outcomes (Gabel, Hilton, and
Nathanson 1997; Chang et al. 2001; Birkmeyer et al. 2005; Newman et al.
2006). We hypothesized a similar association might exist for patient
knowledge of treatment risk and benefits. This variable was taken from
SEER and categorized into three groups: (1) NCI-designated cancer center,
(2) American College of Surgeons (ACoS) cancer program, or (3) no specific
cancer program. We evaluated two sets of surgeon-level independent
variables: (1) breast cancer procedure volume and (2) demographics (years
in practice and gender). The surgeons’ gender was included based on work
showing that patients perceive different communication styles between male
and female physicians (Roter and Hall 2004; Beran et al. 2007). To measure
volume, we recoded the surgeons’ reported number of total breast procedures
in the past year into low (o50 procedures per year) versus high ( 50
procedures per year). Surgeon procedure volume was included based on
research demonstrating that higher procedure volume is associated with
better clinical outcomes (McKee et al. 2002; Hu et al. 2003; Hiotis et al. 2005;
Billingsley et al. 2007; Gilligan et al. 2007). Finally, we evaluated one measure
of patient–surgeon communication: the patient’s report of which treatment
options were discussed (both mastectomy and BCS, mastectomy only, BCS
only). We included this variable because of our hypothesis that patient–
surgeon communication would be associated with patient knowledge of
treatment risk and benefit, regardless of the treatment setting or other surgeon
characteristics.
Mechanistic Variables. Two variables were evaluated to shed light on potential
mechanisms for how patient involvement in decision making related to
knowledge of treatment risk and benefit. The first was respondent’ attitudes
about their actual involvement in the treatment decision, using the Control
Preference Scale, or CPS (Degner, Sloan, and Venkatesh 1997). The second
was a measure of patient attitude toward the concordance between their
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actual and preferred involvement in the decision (Lantz et al. 2005; Hawley
et al. 2007).
Analysis
A sampling weight was calculated for each subject based on the probability of
selection into the study. These probabilities varied by strata defined by stage
at diagnosis (DCIS versus invasive), race/ethnicity (white, AA, Latina/other),
and site (Detroit versus LA). The total weight was then normalized for each site
to maintain the original sample size for statistical testing (Katz et al. 2005a;
Lantz et al. 2005). The weighting scheme thus reflects the knowledge of non-
Asian women diagnosed with DCIS or nonmetastatic invasive breast cancer in
Detroit and Los Angeles during the study period. We first generated descrip-
tive statistics (frequencies, contingency tables and correlation coefficients) for
the patient and surgeon variables. We then evaluated bivariate associations,
including potential multicollinearity, between independent and dependent
variables. To evaluate the impact of surgeon factors, treatment setting and
patient–surgeon communication, we conducted three multivariable logistic
regressions of survival knowledge (correct versus incorrect). In model 1,
we regressed survival knowledge on the patient demographic and clinical
variables. In model 2, we added the surgeons’ characteristics and treatment
location. Model 3 then added the patient–surgeon communication variable.
A final model controlled for all two-way interactions between patient race/
ethnicity, surgeon characteristics, treatment location, and patient–surgeon
communication.
We conducted multinomial logistic regression of recurrence knowledge
in order to retain the three response options, with ‘‘don’t know’’ being the
base, or referent, category to which the other options were compared. We ran
the same three models, plus the model evaluating interactions, for recurrence
knowledge as for survival knowledge. All models accounted for clustering of
patients within surgeon and controlled for site (Detroit or LA). In each model,
variables with missing response categories, with the exception of income, were
dropped (less than 3 percent of the analytic sample).
In separate analyses, we evaluated whether patient attitudes toward
involvement in decision making were possible mechanisms for explaining
knowledge about treatment risks and benefits. We used the measures
described earlier (CPS and concordance between actual and preferred
involvement). We assessed the impact of these variables on race/ethnicity,
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The mean age of women was 60 (range: 29–79). Approximately 73 percent of
the women were white, 18 percent African American (AA) and 9 percent
Latina/other. Approximately two-thirds reported having some college
education or more and 44.8 percent were married. Close to half (46 percent)
reported family incomes of less than $50,000/year. The weighted proportion
of women with DCIS was 22 percent. Eleven percent of patients were treated
at an NCI-designated cancer center, 56 percent at a ACoS facility, and 33
percent at a setting with no designated cancer program. The majority reported
both treatments were discussed (73 percent), 21 percent that BCS only was
discussed, and 6 percent that mastectomy only was discussed.
The mean number of years in practice for surgeons was 17 (range: 1–39)
and 15 percent were female. Approximately half of the surgeons reported a
high breast-related procedure volume ( 50 procedures/year).
Survival and Recurrence Knowledge
Overall, 51 percent of respondents had survival knowledge. About half (48
percent) reported that they did not know the answer to the recurrence ques-
tion, while 15 percent indicated the answer was false and 37 percent indicated
that the answer was true (Table 1).
Bivariate Results
Younger women and those with higher levels of education were significantly
(po.001) more likely to have survival knowledge than their counterparts.
Women with invasive breast cancer were significantly more likely than those
with DCIS to have survival knowledge (po.001). Reporting that the surgeon
discussed both treatment options was associated with having survival knowl-
edge. There was much more uncertainty associated with recurrence knowl-
edge, with 42 percent–60 percent of women in each racial/ethnic group
reporting ‘‘don’t know.’’ Older women and those with less education were
more likely (po.001) than their counterparts to indicate they did not know the
answer to this question. Women who reported that their surgeon discussed
both treatment options were significantly less likely to indicate that they were
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Table 1: Characteristics of Sample of Breast Cancer Patients (N 5 1,132)
Patient Characteristics N Weighted %
Age
o50 years 97 8.5








High school or less 401 35.3
Some college or more 676 59.1
Missing 55 5.6
Marital status










NCI cancer center 128 11.3
ACoS cancer program 631 55.8
No cancer program 373 32.9
Type of treatment discussed
Both discussed 835 72.9
BCS only discussed 223 20.7
Mastectomy only discussed 74 6.4
Survival knowledge




Don’t know 522 46.1
Missing 5 0.4
Recurrence knowledge
The chances that my breast disease will come back after treatment are the same for mastectomy as
for lumpectomy with radiation
True 168 37.0
False 419 14.8
Don’t know 539 47.6
Missing 6 0.5
Stage 0, I, or II breast cancer, tumor o5 cm, and no clinical contraindications to either BCS with
radiation or mastectomy.
ACoS, American College of Surgeons; BCS, breast conserving surgery; DCIS, ductal carcinoma
in situ; NCI, National Cancer Institute.
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uncertain on this question than women whose surgeons discussed mastectomy
or BCS only (po.001). Bivariate analyses showed significant (p  .001) racial/
ethnic differences in survival knowledge (57 percent of whites, 34 percent of
AAs, and 37 percent of Latina/other) (Figure 1a). As well, significant racial/
ethnic differences in recurrence knowledge was found, with whites being sig-
nificantly (p  .05) more likely to answer ‘‘true’’ and significantly less likely to
answer ‘‘don’t know’’ than AA or Latina/other women (Figure 1b).
Multivariable Logistic Regression of Survival Knowledge
Model 1 of Table 2 shows that African American and Latina/other women
were significantly less likely than white women to have survival knowledge,
controlling other demographic and clinical factors (OR: 0.36; 95 percent CI
0.26–0.50 and 0.43; 95 percent CI 0.25–0.73 for AA and Latina race/ethnicity,
respectively). Women with higher levels of education and those who were
married had, more often, survival knowledge than their counterparts (OR:
1.41; 95 percent CI: 1.07–1.84 for education; OR: 1.56; 95 percent CI: 1.16–
2.10 for marital status). Compared with women with family incomes of
$50,000 or more/year, those with lower incomes or those without income data
were significantly less likely to have survival knowledge (OR: 0.64; 95 percent
CI: 0.47–0.87 for o$50,000; OR 0.62; 95 percent CI:0.40–0.95 for those
missing income data). Women with invasive cancer were more likely than
those with DCIS to have survival knowledge (OR: 1.69; 95 percent CI: 1.32–
2.17). Model 2 shows that the inclusion of surgeon factors and treatment
setting did not change the racial/ethnic differences in survival knowledge, nor
were any of these factors significantly independently associated with survival
knowledge. Model 3 shows that although patient–surgeon communication did
not attenuate the racial/ethnic differences in survival knowledge, women who
reported that both treatments were discussed were significantly more likely to
have survival knowledge than those who reported that only one treatment was
discussed (OR: 0.26; 95 percent CI: 0.14–0.47 for mastectomy only; OR:0.64;
95 percent CI: 0.47–0.88 for BCS only).
Multinomial Logistic Regression of Recurrence Knowledge
Table 3 shows the final model (equivalent to Model 3 of Table 2) of recurrence
knowledge. Response options ‘‘true’’ and ‘‘false’’ were both compared with
‘‘don’t know,’’ which served as the base or referent category in this regression.
This table shows that AAs and Latina/other women were less likely than white
women to respond ‘‘true’’ to the recurrence question (versus responding
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‘‘don’t know’’) (OR: 0.41; 95 percent CI: 0.29–0.59 for AAs; OR: 0.55, 95
percent CI: 0.31–0.97 for Latina/other) but were no more likely to respond
‘‘false’’ versus ‘‘don’t know.’’ As with the survival knowledge outcome, in-
cluding the surgeon factors, treatment setting factors, and patient–surgeon
communication did not affect racial/ethnic differences in recurrence knowl-
0
* P≤0.05 for differences among racial/ethnic groups
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Figure 1: (a) Survival Knowledge by Race/Ethnicity.nw (b) Recurrence
Knowledge by Race/Ethnicity.nw
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edge. Also, women who reported that only one option was discussed (either
mastectomy only or BCS only) were significantly (po.001) less likely than
those who reported discussing both options to respond ‘‘true’’ (versus ‘‘don’t
know’’) or ‘‘false’’ (versus ‘‘don’t know’’).
Table 2: Multivariable Logistic Regression of Knowledge about the Survival
Benefit of Mastectomy versus BCS with Radiation (Survival Knowledge)
Model 1 Model 2 Model 3
Patient factors
Age 0.97 (0.95, 0.98) 0.97 (0.95, 0.98) 0.97 (0.95,0.98)
Race/ethnicity
White Referent Referent Referent
African American 0.36 (0.26, 0.50) 0.34 (0.24, 0.48) 0.35 (0.25, 0.50)
Latina/other 0.43 (0.25, 0.73) 0.45 (0.25, 0.72) 0.47 (0.26, 0.81)
Education: some college or more
(versusohigh school or less)
1.41 (1.07, 1.84) 1.43 (1.10,1.88) 1.34 (1.01, 1.77)
Marital status: married
(versus not married)
1.56 (1.16, 2.10) 1.60 (1.18,2.16) 1.59 (1.16, 2.17)
Income
 $50,000/year Referent Referent Referent
o$50,000/year 0.64 (0.47, 0.87) 0.65 (0.48,0.90) 0.68 (0.49, 0.94)
Missing 0.62 (0.40, 0.95) 0.63 (0.41, 0.98) 0.61 (0.39, 0.96)
Tumor behavior: invasive
(versus DCIS)
1.69 (1.32, 2.17) 1.66 (1.30, 2.13) 1.59 (1.22, 2.03)
Surgeon factors and treatment setting
Surgeon years in practice 0.99 (0.97, 1.01) 0.99 (0.96, 1.01)
Surgeon gender: male
(versus female)
1.29 (0.90, 1.83) 1.25 (0.85, 1.81)
Surgeon breast procedure volume:
high (versus low)
0.99 (0.74, 1.33) 0.98 (0.71, 1.35)
Treatment setting
No cancer program Referent Referent
ACoS program 1.11 (0.82, 1.50) 1.09 (0.79, 1.50)
NCI cancer center 1.31 (0.85, 2.01) 1.48 (0.91, 2.39)
Patient–surgeon communication
Communication
Both treatments discussed Referent
Mastectomy only discussed 0.26 (0.14, 0.47)
BCS only discussed 0.64 (0.47, 0.88)
All models applied sampling weights and control for tumor size, geographic location, and clus-
tering by surgeon. Including family history of breast cancer did not affect the results. Models
including patient involvement in decision making and all two-way interactions between race/
ethnicity and other factors are not shown.
ACoS, American College of Surgeons; BCS, breast conserving surgery; DCIS, ductal carcinoma
in situ; NCI, National Cancer Institute.
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Table 3: Multinomial Logistic Regression of Knowledge about the Recurrence
Risk of Mastectomy versus BCS With Radiation (Recurrence Knowledge)
The Chances That My Breast Disease Will Come Back
after Treatment Are the Same for Mastectomy as for
Lumpectomy with Radiation
True versus Don’t Know False versus Don’t Know
OR (95% CI) OR (95% CI)
Patient factors
Age 0.96 (0.95, 0.97) 0.94 (0.92, 0.96)
Race/ethnicity
White Referent Referent
African American 0.41 (0.29, 0.59) 0.74 (0.46, 1.20)
Latina/other 0.55 (0.31, 0.97) 0.51 (0.24, 1.06)
Education: some college or more
(versus ohigh school or less)
1.30 (0.97, 1.75) 1.53 (1.03, 2.28)
Marital status: married
(versus not married)
1.55 (1.13, 2.11) 1.58 (1.10, 2.27)
Income
 $50,000/year Referent Referent
o$50,000/year 0.76 (0.54, 1.07) 1.02 (0.68, 1.55)
Missing 0.66 (0.41, 1.07) 0.91 (0.48, 1.74)
Tumor behavior: invasive
(versus DCIS)
1.77 (1.31, 2.38) 0.87 (0.63, 1.22)
Surgeon factors and treatment setting
Surgeon years in practice 0.99 (0.97, 1.01) 1.00 (0.98, 1.02)
Surgeon gender: male
(versus female)
1.23 (0.85, 1.79) 0.88 (0.52, 1.47)
Surgeon breast procedure volume:
high (versus low)
1.06 (0.76, 1.48) 1.03 (0.74, 1.43)
Treatment setting
No cancer program Referent Referent
ACoS program 1.04 (0.74, 1.43) 1.08 (0.75, 1.53)
NCI cancer center 1.09 (0.70, 1.69) 0.92 (0.49, 1.60)
Patient-surgeon communication
Communication
Both treatments discussed Referent Referent
Mastectomy only discussed 0.36 (0.19, 0.66) 0.20 (0.08, 0.50)
BCS only discussed 0.69 (0.49, 0.96) 0.44 (0.28, 0.70)
Multinomial base, or referent, category is ‘‘don’t know.’’
Prior models included: (1) patient factors only; (2) patient factors, surgeon factors, and treatment
setting. Results did not differ significantly from those presented in this full model (patient factors,
surgeon factors, treatment setting, and patient–surgeon communication).
All models applied sampling weights and controlled for geographic site, tumor size, and clustering
by surgeon. Inclusion of family history of breast cancer did not affect the results.
Models showing patient involvement in decision making and all two-way interactions not shown.
ACoS, American College of Surgeons; BCS, breast conserving surgery; DCIS, ductal carcinoma
in situ; NCI, National Cancer Institute.
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Interactions and Mechanistic Analyses
Neither patient reported involvement nor concordance between actual and
preferred involvement were significantly associated with either survival or
recurrence knowledge outcomes (results not shown). Importantly, including
these variables in the model did not impact any of the prior results; observed
racial/ethnic differences remained in both knowledge measures. None of the
two-way interactions included in the multivariate regression were significantly
associated with either type of knowledge (results not shown). Including the
interactions also did not impact the racial/ethnic disparities observed in
survival or recurrence knowledge.
DISCUSSION
Results from this analysis confirm that knowledge about the risks and benefits
of breast cancer treatment options needs to be improved among all patients
(Nold et al. 2000; Bluman et al. 2001; Fagerlin et al. 2006), but particularly for
racial/ethnic minorities (Maly, Leake, and Silliman 2004; Siminoff, Graham,
and Gordon 2006; Polacek, Ramos, and Ferrer 2007). Perhaps the most con-
cerning finding from this analysis was the persistence of racial/ethnic differ-
ences in breast cancer treatment knowledge despite controlling for surgeon
characteristics, treatment location, and patient–surgeon communication. Hav-
ing adequate knowledge of risks and benefits of treatment options is a key
element of an informed and a high quality breast cancer treatment decision
(Rimer et al. 2004; Sepucha et al. 2007). Moreover, the discussion of both
treatment options with eligible breast cancer patients is mandated by law in 20
states, including MI and CA (Nayfield et al. 1994; Montini 1997). These results
are consistent with our argument in prior research that efforts to improve the
quality of breast cancer care should focus on improving the process of decision
making (Katz and Hawley 2007), and that efforts to improve decision making
are especially needed for racial/ethnic minority women with breast cancer
(Polacek, Ramos, and Ferrer 2007).
Research has shown that provider characteristics, such as high proce-
dure volume, and treatment setting factors, such as access to multidisciplinary
care, are associated with positive clinical outcomes (Gabel, Hilton, and Na-
thanson 1997; Chang et al. 2001; McKee et al. 2002; Hu et al. 2003; Birkmeyer
et al. 2005; Hiotis et al. 2005; Hawley et al. 2006; Newman et al. 2006; Bill-
ingsley et al. 2007; Gilligan et al. 2007). However, little has been done to link
these factors to decision outcomes, such as knowledge about treatment options
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or satisfaction with the decision process. Results from a recent pilot study
showed that including patients in multidisciplinary clinic discussions related to
breast cancer treatment planning was highly valued by patients themselves
(Choy et al. 2007). A few studies have shown that a multidisciplinary approach
to breast cancer care, such as referral to a radiation oncologist, medical on-
cologist, or plastic surgeon, before initial surgical decision influences the treat-
ment chosen (Alderman et al. 2008; Keating et al. 2003; Baldwin et al. 2004).
Liang and colleagues have demonstrated an association between higher breast
procedure volume and a surgeon’s likelihood of initiating treatment discussions
with patients (Liang et al. 2002). A recent study by our team found higher
satisfaction with breast cancer treatment decision making among patients with
a high volume surgeon (Waljee et al. 2007). These studies provide a possible
connection between factors typically linked to high quality care and high
quality decision making, yet none evaluated this issue with respect to racial/
ethnic minority women with breast cancer. Our results showed that neither
provider characteristics nor treatment setting attenuated observed racial/ethnic
disparities in knowledge, nor were these factors independently associated with
knowledge about breast cancer treatment risks and benefits. These results sug-
gest that factors linked with quality care may be less important for informed
decision making, and that improvements in how treatment information is
communicated to patients is needed across providers and practice settings.
In fact, our results suggest that the gap in the delivery of accurate risk and
benefit information from surgeons to patients may be especially large for
racial/ethnic minority women. This analysis found that having a surgeon who
discussed both treatment options significantly improved both survival and
recurrence knowledge but did not attenuate racial/ethnic disparities. These
results imply that while it is critical for surgeons to effectively deliver infor-
mation about treatment options, this information may be comprehended
differently by patients of different racial/ethnic groups. There has been con-
siderable work documenting the importance of communication and shared
decision making in patient satisfaction with breast cancer treatment decisions
(Mandelblatt et al. 2001; Liang et al. 2002; Maly, Leake, and Silliman 2004;
Siminoff, Graham, and Gordon 2006). Yet few studies have objectively eval-
uated the role of communication on patient knowledge of the risks and ben-
efits of treatment options, and virtually none have assessed this issue for racial/
ethnic minority women. Siminoff, Graham, and Gordon (2006) found that
providers communicated differently about breast cancer treatment with pa-
tient of different race/ethnicities, educational and income levels. Gordon and
colleagues (Gordon et al. 2006) also found African American patients received
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less information about different medical treatments than white patients. These
studies, with our results, underscore the need for providers to communicate
information effectively to all patients. Our results also support the literature
suggesting that improving the communication skills and cultural competency
of providers a necessary step to reducing health disparities ( Johnson et al.
2004; Betancourt 2006; Giger, Davidhizar, and Fordham 2006; Lloyd et al.
2006). Our results are consistent with the conclusion of a recent review by
Polacek, Ramos, and Ferrer (2007), specifically in that ensuring high quality
breast cancer outcomes for all women is dependent on culturally and ethni-
cally appropriate professional support.
Increasing patient involvement in decision making has also been identified
as a potential mechanism for achieving informed treatment decisions in breast
cancer (National Cancer Policy Board 1999; Mandelblatt et al. 2001; Maly,
Leake, and Silliman 2003). Yet some research suggests that helping patients
achieve their desired amount of involvement is more important than simply
increasing their participation in the decision (Bruera et al. 2002; Janz
et al. 2004; Maly et al. 2004; Lantz et al. 2005). We evaluated patient attitudes
about their involvement in the surgical treatment decision as possible mecha-
nisms for explaining differences in treatment knowledge. We found that neither
actual involvement nor concordance between actual-preferred involvement at-
tenuated racial/ethnic differences in knowledge or was independently associated
with knowledge. Temple and colleagues (2006) found that only 14% of breast
cancer patients reported having enough information. This result, combined with
that described above, suggests that while improving patient involvement in
decision making is an important goal, the content of the discussion is clearly
more important for ensuring accurate knowledge of treatment risk and benefit.
Our study has some limitations. First, despite a large population-based
patient sample, it is only representative of two cities in the United States and of
non-Asian women. Although we achieved very high surgeon (80 percent) and
patient (77 percent) response rates, the fact that not all patients were merged to
surgeons could affect the generalizability of the results. Second, there is the
limitation of possible recall bias, due to the self-reported nature of measures and
that the mean time between diagnosis and survey was 7 months. In addition,
there is the potential limitation of selection bias, because patients with higher
knowledge initially may be more likely seen at NCI cancer centers or other
multidisciplinary centers. However when we re-ran analyses including a vari-
able measuring whether women selected or were referred to their surgeon, we
did not find any significant differences in the results. Third, our outcome mea-
sures, reflecting knowledge of the risks and benefits of the two surgical treatment
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options, do not account for the many other types of treatments often required by
breast cancer patients. Finally, because this was a cross-sectional survey, our
results demonstrate associations between factors rather than causal relationships.
Despite significant gains in the longevity of patients with breast cancer,
there continues to be evidence of racial/ethnic disparities in breast cancer
treatment (Morris et al. 2000; Jatoi, Becher, and Leake 2003; Hershman et al.
2005; Naeim et al. 2006; Simon et al. 2006). The ability to make an informed
treatment decision is not only an important indicator of quality care, it is
mandated in 20 states (Nayfield et al. 1994; Montini 1997). We found racial/
ethnic disparities in knowledge about risks and benefits of breast cancer sur-
gical treatment options were not affected by factors typically associated with
high quality care, such as surgeon volume and treatment setting. Patients’
reporting that both treatment options were discussed was the strongest pre-
dictor of survival knowledge, but did not attenuate racial/ethnic disparities.
Implications from this study include the need for more attention to the way in
which information about the risks and benefits of treatment options are com-
municated to patients by their providers. Decision tools to improve informed
decision making for breast cancer patients are needed across surgeons and
treatment settings, and may need to be tailored to race/ethnicity, accultur-
ation, and literacy. These approaches to improving the delivery of information
to breast cancer patients faced with surgical treatment decisions are likely to
result in measurable reductions in racial/ethnic disparities in informed deci-
sion making and improvements in decision quality.
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